NCT00504257View on ClinicalTrials.gov

Avastin in Combination With Docetaxel in Ovarian/Fallopian Tube/Peritoneum Carcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Fallopian Tube CancerOvarian CancerMalignant Tumor of Peritoneum
Interventions
DRUG

Avastin

Day 1, every 21 day cycle

DRUG

Docetaxel

Day 1, 8, every 21 day cycle

Trial Locations (4)

27710

Duke Cancer Institute, Durham

33316

Broward General Medical Center Cancer Center, Fort Lauderdale

33701

Women's Cancer Associates, St. Petersburg

33612-9497

H. Lee Moffitt Cancer Center and Research Institute, Tampa

Sponsors

Collaborators (2)

Genentech, Inc.
Sanofi
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Genentech, Inc.

INDUSTRY

collaborator

Sanofi

INDUSTRY

lead

H. Lee Moffitt Cancer Center and Research Institute

OTHER